These findings, in combination with the TNF-α and IL1-β induced Sema4B expression by FLS, suggest that these mediators, which are highly expressed in the synovium of patients with RA [28], are responsible of the elevated Sema4B expression. The gene discussed is SEMA4B; the disease is rheumatoid arthritis.